Retrospective Study in a NSCLC M+ p

This is a national, multicentre, non-interventional, retrospective study to be carried out in the oncology settings of approximately 15-20 Spanish hospitals. At each participant hospital, all patient...

Lead sponsor: AstraZeneca•12 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Start Free Trial

Related studies

RECRUITINGPhase 1

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

NCT07315113 · EGFR Mutation Positive Non-small Cell Lung Cancer, EGFR Mutated Non-small Cell Lung Cancer Patients

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 30, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment187

Start dateMar 2013

Last updatedOct 30, 2013

Condition

EGFR Mutated Non-small Cell Lung Cancer Patients

Locations shown

Research Site

Barcelona, Barcelona

Research Site

Córdoba, Cordoba

Research Site

Donostia / San Sebastian, Donostia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2013Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Retrospective Study in a NSCLC M+ p

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Sponsors

Related studies

Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

Trial snapshot

Condition

Locations shown

For caregivers